← FDA DRUG APPROVALS

FDA ANDA · ANDA211432

SUCCINYLCHOLINE CHLORIDE

Sponsor: AMNEAL

APPLICATION
ANDA211432
TYPE
ANDA
ORIGINAL APPROVAL
2018-11-16
LATEST ACTION
2023-07-28
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SUCCINYLCHOLINE CHLORIDEDiscontinued
SUCCINYLCHOLINE CHLORIDE 20MG/ML · INJECTABLE · INJECTION

Approval history

2023-07-28Labeling · Supplement 11 · standardAP
2022-04-20Labeling · Supplement 9 · standardAP
2021-02-24Labeling · Supplement 6 · standardAP
2018-11-16UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →